Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease

Sunku H Guptha; Anthony D Promnitz

doi:10.1016/j.ejim.2004.09.014

Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease

Eur J Intern Med. 2005 Apr;16(2):129-131. doi: 10.1016/j.ejim.2004.09.014.

Authors

Sunku H Guptha¹, Anthony D Promnitz

Affiliation

¹ Edith Cavell Hospital, Peterborough PE3 9GZ, UK.

PMID: 15833682
DOI: 10.1016/j.ejim.2004.09.014

Abstract

A 62-year-old Caucasian man with a history of Parkinson's disease developed bilateral pleural thickening and a large, right-sided, exudative pleural effusion. Further investigations revealed a chronic inflammatory process involving the pleura as a result of exposure to cabergoline used to treat the Parkinson's disease. The inflammatory process reversed after the discontinuation of cabergoline.